Type 2 Diabetes

Although hemodialysis is a commonly used treatment for kidney failure, a recent study has shown it may not be as beneficial for people who develop a sudden case of the condition.

Insulin, a peptide hormone, can protect the cells of the pancreas from acute pancreatitis – a disease for which there is currently no cure, according to a study by scientists from The University of Manchester.

Use these 5 brief summaries of recent developments in the study of diabetes and trends in diabetes care to stay current and optimize care for your patients.

According to the results of a recent study, hospitalized patients may be able to know well in advance whether they are at risk of being diagnosed with type 2 diabetes in the future.

Researchers have manufactured a peptide aimed to block modified proteins associated with Alzheimer's disease, Parkinson's disease, heart disease, type 2 diabetes, Lou Gehrig's disease, and other conditions.

Diabetic neuropathic pain can be controlled with a low-fat vegan diet, according to research presented at the American Association of Diabetic Educators Annual Meeting.

If the BCGS model is accurate, brain and periphery communicate continuously about glucose homeostasis and a change in the brain can alter insulin sensitivity in the periphery. Read this review, and you'll be up-to-date.

The US Food and Drug Administration recently announced the approval of the KRONUS Zinc Transporter 8 Autoantibody (ZnT8Ab) ELISA Assay, a new test for type 1 diabetes.

Every year, more and more Americans are diagnosed with type 2 diabetes mellitus and, according to a recent study, in the near future that number could reach close to 40% of the population.

A new drug was given tentative approval by the US Food and Drug Administration to help patients with both type 1 and type 2 diabetes.

Studies looking at add-on treatment with SGLT2 inhibitors show their effects on glycemic control to be roughly additive. Here, a concise look at clinical trial results plus guidance on renal dose adjustment.

The 5 slides here provide highlights of recent studies of diabetes and - offer a variety of practical pointers and information that can be put to use in your practice.

Fixed-dose tablet is the first sodium glucose cotransporter 2 (SGLT2) inhibitor plus metformin combo product to receive approval in the US.

Although variouis contraceptives are available for women whose baseline health is good, women who have chronic medical conditions have unique concerns.

Just 6% of individuals with pancreatic cancer live 5 years after diagnosis, and almost half of newly diagnosed pancreatic cancer presents as new-onset diabetes mellitus.

Despite hesitation from patients and other barriers in the healthcare industry, clinicians should encourage patients with type 2 diabetes to switch to insulin much earlier in the disease.

The Endocrine Society and the American Association of Clinical Endocrinologists have released a list of 5 unnecessary tests and procedures as part of the Choosing Wisely project.

Online support groups, YouTube videos on injection technique, healthy lifestyle sites--good patient information abounds on the Web. But so do the bad and the ugly. I try to help my patients discriminate; I'm not always successful.

The term pre-diabetes has limited clinical value as a majority of patients who fall into the category do not go on to develop type 2 diabetes, according to researchers.

Empagliflozin is the third sodium-glucose cotransporter 2 inhibitor approved for use in the US. There is a lot to learn about this new class. Here, 5 of the many things you need to know.

Early research shows that this kind of program decreases distress and lowers blood sugar levels.

Anxiety was decreased and blood sugar levels were lowered in this pilot study.

Patients with painful diabetic polyneuropathy can have higher nocturnal blood pressure, according to a study published in Diabetes Care.

Researchers examine whether patients with hypertension, diabetes, and hyperlipidemia saw improved health outcomes after Massachusetts Health Reform was implemented in 2006.

As life expectancies for cystic fibrosis patients have increased, so have possible long-term complications such as diabetes.

This patient's presenting symptom, in the context of his overall health, should prompt orders for which follow-up studies?

Burning foot pain in a patient with long-standing T2DM should prompt evaluation for other potential microvascular complications.

Despite these improvements in medical technology, diabetic nephropathy remains unpredictable and life-threatening. Identifying high-risk patients at an early stage could help clinicians take appropriate steps to reduce risk.